Maternal care for anti-D [Rh] antibodies, first trimester (not applicable or unspecified)
ICD-10 O36.0110 is a billable code used to indicate a diagnosis of maternal care for anti-d [rh] antibodies, first trimester (not applicable or unspecified).
O36.0110 refers to maternal care provided to pregnant women who have developed anti-D (Rh) antibodies during the first trimester of pregnancy. This condition arises when an Rh-negative mother is exposed to Rh-positive blood, often from a previous pregnancy or transfusion. The presence of these antibodies can lead to hemolytic disease of the fetus and newborn (HDFN), which can cause fetal complications such as anemia, jaundice, and in severe cases, fetal distress or intrauterine growth restriction (IUGR). Monitoring and management strategies are crucial during this period to assess fetal well-being and growth, as well as to prevent potential complications. Regular ultrasounds and blood tests are typically performed to evaluate fetal health and detect any signs of distress or growth issues. The management of anti-D antibodies may involve the administration of Rh immunoglobulin (RhoGAM) to prevent further sensitization and protect future pregnancies.
Documentation must include maternal blood type, antibody screening results, and any interventions taken.
Routine prenatal visits where anti-D antibodies are identified, and monitoring for fetal growth restriction.
Ensure that all fetal assessments are documented, including ultrasound findings and any interventions.
Detailed records of high-risk assessments, including fetal echocardiograms and blood flow studies.
Management of pregnancies complicated by anti-D antibodies with close monitoring for fetal anemia.
Collaboration with neonatology for potential postnatal interventions.
Used for comprehensive obstetric care for patients with anti-D antibodies.
Complete documentation of all prenatal visits, including antibody testing and fetal monitoring.
Ensure that all relevant maternal-fetal interactions are documented.
Anti-D antibodies can lead to serious fetal complications if not monitored and managed properly. They can cause hemolytic disease of the newborn, which may result in anemia, jaundice, or even fetal distress. Regular monitoring and appropriate interventions are crucial.
